# EDGAR Filing Document

**Accession Number:** 0001386301
**File Stem:** 0001104659-26-014422
**Filing Date:** 2026-2
**Character Count:** 29812
**Document Hash:** ead32bc2ad683af4b945d32a71ac848d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-014422.hdr.sgml**: 20260212

**ACCESSION NUMBER**: 0001104659-26-014422

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260212

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260212

**DATE AS OF CHANGE**: 20260212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Research Solutions, Inc.
- **CENTRAL INDEX KEY:** 0001386301
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39256
- **FILM NUMBER:** 26627612

**BUSINESS ADDRESS:**
- **STREET 1:** 10624 S. EASTERN AVE
- **STREET 2:** SUITE A-614
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89052
- **BUSINESS PHONE:** 310 477 0354

**MAIL ADDRESS:**
- **STREET 1:** 10624 S. EASTERN AVE
- **STREET 2:** SUITE A-614
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89052

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Derycz Scientific Inc
- **DATE OF NAME CHANGE:** 20070112

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report:

(Date of earliest event reported)

**February 12, 2026**

**Research Solutions, Inc.**

(Exact name of registrant as specified in its charter)

**Nevada**

(State or other Jurisdiction of Incorporation)

---

| | |
|:---|:---|
| &nbsp;&nbsp;**1-39256** | &nbsp;&nbsp;**11-3797644** |
| &nbsp;&nbsp;(Commission File Number) | &nbsp;&nbsp;(IRS Employer Identification No.) |

---

**N/A<sup>1</sup>**

(Address of Principal Executive Offices and zip code)

**(310) 477-0354**

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;<u>Title of each Class</u> | &nbsp;&nbsp;<u>Trading Symbol(s)</u> | &nbsp;&nbsp;<u>Name of each Exchange on which registered</u> |
| &nbsp;&nbsp;Common stock, $0.001 par value | &nbsp;&nbsp;RSSS | &nbsp;&nbsp;The Nasdaq Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp; ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp; ◻

<sup>1</sup> In November 2019, we became a fully remote company. Accordingly, we do not currently have principal executive offices. Our mailing address is 10624 S. Eastern Ave., Ste. A-614, Henderson, NV 89052.

**Item 2.02 Results of Operations and Financial Condition.**

 

On February 12, 2026, the Registrant announced its financial results for the second quarter ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits** |

---

(d) Exhibits.

---

| | |
|:---|:---|
| Exhibit <br> Number | Description |
| [99.1](tm266147d1_ex99-1.htm) | [Press Release issued February 12, 2026 entitled "Research Solutions Reports Second Quarter Fiscal Year 2026 Results".](tm266147d1_ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded as Inline XBRL document). |

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **RESEARCH SOLUTIONS, INC.** | **RESEARCH SOLUTIONS, INC.** |
| Date: February 12, 2026 | By: | /s/ David Kutil |
|  |  | David Kutil |
|  |  | Interim Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**FOR IMMEDIATE RELEASE**

![](tm266147d1_ex99-1img001.jpg)

**Research Solutions Reports Second Quarter Fiscal Year 2026 Results**

*Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA* 

**HENDERSON, Nev., February 12, 2026** — **Research Solutions, Inc.** (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025.

**Fiscal Second Quarter 2026 Summary (compared to prior-year quarter)**

· Annual
 Recurring Revenue ("ARR") up 14% to $21.8 million, which includes approximately
 $15.3 million of B2B ARR and $6.4 million of B2C ARR.

· Forty-seven
 net new deployments in the quarter reflect one of our best results and sustained momentum
 in new B2B customer acquisition.

· Net
 income of $547,000, or $0.02 per diluted share, compared to net loss of $2.0 million or ($0.07)
 per share.

· Adjusted
 EBITDA increased 36% to $1.3 million. On a trailing twelve-month ("TTM") basis,
 the Company has now generated Adjusted EBITDA of $5.8 million or 11.8% of revenue for
 the same period.

· Net
 B2B ARR growth of $560,000 represents the best organic second quarter performance in
 Company history.

· Gross
 profit up 6% to $6.2 million. Total gross margin improved 350 basis points to 52.4%.

· Platform
 revenue up 14% to $5.2 million. Platform revenue accounted for 44% of total revenue as compared
 to 39% in the prior-year quarter.

· Total
 revenue was $11.8 million compared to $11.9 million in the prior year, as strong B2B revenue
 growth has not yet fully offset softness in transactions revenue.

"Our second quarter results reflect strong growth within our B2B Platforms business through forty-seven net new deployments in the quarter and Platforms continues to represent a larger portion of our total revenue mix. In addition, the average sales price for our Platform increased more than six percent year-over-year as we signed larger deals and as existing customers adopt more of our SaaS and AI solutions," said Roy W. Olivier, President and CEO of Research Solutions. "Our business continues to generate strong operating cash flow and Adjusted EBITDA, allowing us to reinvest in sales and marketing to accelerate growth while maintaining financial flexibility. We continue to manage the business with a long-term focus to drive value for our shareholders."

**Fiscal Second Quarter 2026 Results**

Total revenue was $11.8 million, compared to $11.9 million in the year-ago quarter. Platform revenue growth was offset by a decline in transactions revenue.

Platform subscription revenue for the quarter was $5.2 million, a 14% year-over-year increase from the prior-year period. The increase was primarily due to organic growth in the core B2B platform, due to a mix of new logo generation as well as upsells and cross-selling into existing customers. The quarter ended with annual recurring revenue of $21.8 million, up 14% year-over-year (see the Company's definition of annual recurring revenue below).

Transaction revenue was $6.6 million, compared to $7.3 million in the second quarter of fiscal 2025. The decrease was due to the impact of a known customer that churned earlier and a few larger customers that saw significant declines in volume. The transaction active customer count for the quarter was 1,321, compared to 1,384 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).

Total gross margin improved 350 basis points from the prior-year quarter to 52.4%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business, including the expansion of the gross margin for that business.

Total operating expenses were $5.4 million, compared to $5.7 million in the second quarter of fiscal 2025. The decrease was primarily related to reduced general and administrative and stock-based compensation expenses offset in part by increased sales and marketing expenses.

Net income in the fiscal second quarter was $547,000, or $0.02 per diluted share, compared to a net loss of $2 million, or ($0.07) per share, in the prior-year quarter. Adjusted EBITDA was $1.3 million, compared to $963,000 in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

**Conference Call**

Management will host the conference call, followed by a question-and-answer period.

Date: Thursday, February 12, 2026

Time: 5:00 p.m. ET (2:00 p.m. PT)

Dial-in number: 1-203-518-9708

Conference ID: RESEARCH

The conference call will be broadcast live and available for replay until March 12, 2026 by dialing 1-412-317-6671 and using the replay ID 11160799, and via the investor relations section of the Company's website at <u>http://researchsolutions.investorroom.com/</u>.

**Fiscal Second Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2025** | **2024** | **Change** | **% Change** | **2025** | **2024** | **Change** | **% Change** |
| Revenue: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Platforms | $5224845 | $4601257 | $623588 | 13.6% | $10345685 | $8930902 | $1414783 | 15.8% |
| &nbsp;&nbsp;&nbsp;Transactions | 6567806 | 7312962 | (745156) | -10.2% | 13759151 | 15027799 | (1268648) | -8.4% |
| Total Revenue | 11792651 | 11914219 | (121568) | -1.0% | 24104836 | 23958701 | 146135 | 0.6% |
| Gross Profit: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Platforms | 4602184 | 3981415 | 620769 | 15.6% | 9112649 | 7763893 | 1348756 | 17.4% |
| &nbsp;&nbsp;&nbsp;Transactions | 1574766 | 1839678 | (264912) | -14.4% | 3289599 | 3823076 | (533477) | -14.0% |
| Total Gross Profit | 6176950 | 5821093 | 355857 | 6.1% | 12402248 | 11586969 | 815279 | 7.0% |
| Gross profit as a % of revenue: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Platforms | 88.1% | 86.5% | 1.6% |  | 88.1% | 86.9% | 1.1% |  |
| &nbsp;&nbsp;&nbsp;Transactions | 24.0% | 25.2% | -1.2% |  | 23.9% | 25.4% | -1.5% |  |
| Total Gross Profit | 52.4% | 48.9% | 3.5% |  | 51.5% | 48.4% | 3.1% |  |
| Operating Expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 1648597 | 1343087 | 305510 | 22.7% | 3315422 | 2533494 | 781928 | 30.9% |
| &nbsp;&nbsp;&nbsp;Technology and product development | 1602421 | 1506849 | 95572 | 6.3% | 3012572 | 2879607 | 132965 | 4.6% |
| &nbsp;&nbsp;&nbsp;General and administrative | 1620595 | 2008201 | (387606) | -19.3% | 3295954 | 3938377 | (642423) | -16.3% |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 316425 | 306233 | 10192 | 3.3% | 632491 | 618328 | 14163 | 2.3% |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 213449 | 534322 | (320873) | -60.1% | 425931 | 952311 | (526380) | -55.3% |
| &nbsp;&nbsp;&nbsp;Foreign currency translation loss (gain) | 36112 | 29554 | 6558 | 22.2% | 18856 | (74686) | 93542 | -125.2% |
| Total Operating Expenses | 5437599 | 5728246 | (290647) | -5.1% | 10701226 | 10847431 | (146205) | -1.3% |
| Income from operations | 739351 | 92847 | 646504 | 696.3% | 1701022 | 739538 | 961484 | -130.0% |
| Other expense: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other expense | (183572) | (2057887) | 1874315 | -91.1% | (374625) | (1989362) | 1614737 | -81.2% |
| &nbsp;&nbsp;&nbsp;Provision for income taxes | (8859) | (15194) | 6335 | -41.7% | (30090) | (61406) | 31316 | -51.0% |
| Total Other Expense: | (192431) | (2073081) | 1880650 | -90.7% | (404715) | (2050768) | 1646053 | -80.3% |
| Net income (loss) | $546920 | $(1980234) | 2527154 | -127.6% | $1296307 | $(1311230) | 2607537 | -198.9% |
| Adjusted EBITDA | $1305337 | $962956 | $342381 | 35.6% | $2778300 | $2235491 | $542809 | 24.3% |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2025** | **2024** | **Change** | **% Change** | **2025** | **2024** | **Change** | **% Change** |
| **Platforms:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;B2B ARR (Annual recurring revenue\*): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period | $14758472 | $12187834 | $2570637 | 21.1% | $14197598 | $12060201 | $2137397 | 17.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incremental ARR | 560482 | 550422 | 10060 | 1.8% | 1121356 | 678055 | 443301 | 65.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of Period | $15318954 | $12738256 | $2580697 | 20.3% | $15318954 | $12738256 | $2580698 | 20.3% |
| &nbsp;&nbsp;&nbsp;Deployments: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period | 1185 | 1029 | 156 | 15.2% | 1171 | 1021 | 150 | 14.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incremental Deployments | 47 | 61 | (14) | -23.0% | 61 | 69 | (8) | -11.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of Period | 1232 | 1090 | 142 | 13.0% | 1232 | 1090 | 142 | 13.0% |
| &nbsp;&nbsp;&nbsp;ASP (Average sales price): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period | $12454 | $11844 | $610 | 5.2% | $12124 | $11812 | $312 | 2.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of Period | $12434 | $11686 | $748 | 6.4% | $12434 | $11686 | $748 | 6.4% |
| &nbsp;&nbsp;&nbsp;B2C ARR (Annual recurring revenue\*): |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of Period | $6535197 | $5430795 | $1104402 | 20.3% | $6721356 | $5363129 | $1358227 | 25.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incremental ARR | (93781) | 940586 | (1034367) | -110.0% | (279940) | 1008252 | (1288192) | -127.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of Period | $6441416 | $6371381 | $70035 | 1.1% | $6441416 | $6371381 | $70035 | 1.1% |
| &nbsp;&nbsp;&nbsp;Total ARR (Annualized recurring revenue): | $21760370 | $19109637 | $2650732 | 13.9% | $21760370 | $19109637 | $2650733 | 13.9% |
| **Transaction Customers:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Corporate customers | 1326 | 1051 | 275 | 26.2% | 1200 | 1063 | 137 | 12.9% |
| &nbsp;&nbsp;&nbsp;Academic customers | 324 | 333 | (9) | -2.7% | 320 | 325 | (5) | -1.5% |
| &nbsp;&nbsp;&nbsp;Total customers | 1650 | 1384 | 266 | 19.2% | 1520 | 1388 | 132 | 9.5% |

---

\* Annual Recurring Revenue (Non-GAAP Measure) - the value of contracted platform subscription recurring revenue normalized to a one year period. For B2C, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by 12.

**Active Customer Accounts, Transactions and Annual Recurring Revenue**

The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

**Use of Non-GAAP Measure – Adjusted EBITDA**

Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results.

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Quarter Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2025** | **2024** | **Change** | **% <br> Change** | **2025** | **2024** | **Change** | **% <br> Change** |
|  | $546920 | $(1980234) | $2527154 | -127.6% | $1296307 | $(1311230) | $2607537 | -198.9% |
| Other expense | 183572 | 2057887 | (1874315) | -91.1% | 374625 | 1989362 | (1614737) | -81.2% |
| Foreign currency translation loss (gain) | 36112 | 29554 | 6558 | 22.2% | 18856 | (74686) | 93542 | -125.2% |
| Provision for income taxes | 8859 | 15194 | (6335) | -41.7% | 30090 | 61406 | (31316) | -51.0% |
| Depreciation and amortization | 316425 | 306233 | 10192 | 3.3% | 632491 | 618328 | 14163 | 2.3% |
| Stock-based compensation | 213449 | 534322 | (320873) | -60.1% | 425931 | 952311 | (526380) | -55.3% |
|  | $1305337 | $962956 | $342381 | 35.6% | $2778300 | $2235491 | $542809 | -24.3% |

---

**About Research Solutions**

Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit **<u>www.researchsolutions.com</u>**

**Important Cautions Regarding Forward-Looking Statements**

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to officially release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

**Research Solutions, Inc. and Subsidiaries**

**Condensed Consolidated Balance Sheets (Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2025** | **June 30,**<br>**2025** |
| **Assets** |  |  |
| **Current assets:** |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $12262780 | $12227312 |
| &nbsp;&nbsp;Accounts receivable, net of allowance of $79,869 and $182,324, respectively | 5661171 | 7191234 |
| &nbsp;&nbsp;Prepaid expenses and other current assets | 708075 | 580257 |
| &nbsp;&nbsp;Prepaid royalties | 42155 | 925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 18674181 | 19999728 |
| **Non-current assets:** |  |  |
| &nbsp;&nbsp;Property and equipment, net of accumulated depreciation of $992,832 and $964,883, respectively | 65236 | 60769 |
| &nbsp;&nbsp;Intangible assets, net of accumulated amortization of $3,347,683 and $2,736,773, respectively | 9130484 | 9686241 |
| &nbsp;&nbsp;Goodwill | 16372979 | 16372979 |
| &nbsp;&nbsp;Deposits and other assets | 1000 | 957 |
| **Total assets** | $44243880 | $46120674 |
| **Liabilities and Stockholders' Equity** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;Accounts payable and accrued expenses | $6397476 | $7443757 |
| &nbsp;&nbsp;Deferred revenue | 9916853 | 10702120 |
| &nbsp;&nbsp;Contingent earnout liability, current portion | 7295596 | 7363152 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 23609925 | 25509029 |
| **Non-current liabilities:** |  |  |
| &nbsp;&nbsp;Contingent earnout liability, long-term portion | 3405356 | 6683488 |
| **Total liabilities** | 27015281 | 32192517 |
| **Commitments and contingencies** |  |  |
| **Stockholders' equity:** |  |  |
| &nbsp;&nbsp;Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding |  |  |
| &nbsp;&nbsp;Common stock; $0.001 par value; 100,000,000 shares authorized; 32,875,476 and 32,479,993 shares issued and outstanding, respectively | 32875 | 32480 |
| &nbsp;&nbsp;Additional paid-in capital | 41056472 | 39059557 |
| &nbsp;&nbsp;Accumulated deficit | (23747387) | (25043693) |
| &nbsp;&nbsp;Accumulated other comprehensive loss | (113361) | (120187) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 17228599 | 13928157 |
| **Total liabilities and stockholders' equity** | $44243880 | $46120674 |

---

See notes to condensed consolidated financial statements

**Research Solutions, Inc. and Subsidiaries**

**Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenue: |  |  |  |  |
| &nbsp;&nbsp;Platforms | $5224845 | $4601257 | $10345685 | $8930902 |
| &nbsp;&nbsp;Transactions | 6567806 | 7312962 | 13759151 | 15027799 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenue | 11792651 | 11914219 | 24104836 | 23958701 |
| Cost of revenue: |  |  |  |  |
| &nbsp;&nbsp;Platforms | 622661 | 619842 | 1233036 | 1167009 |
| &nbsp;&nbsp;Transactions | 4993040 | 5473284 | 10469552 | 11204723 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total cost of revenue | 5615701 | 6093126 | 11702588 | 12371732 |
| Gross profit | 6176950 | 5821093 | 12402248 | 11586969 |
| **Operating expenses:** |  |  |  |  |
| &nbsp;&nbsp;Selling, general and administrative | 5121175 | 5422013 | 10068736 | 10229103 |
| &nbsp;&nbsp;Depreciation and amortization | 316425 | 306233 | 632491 | 618328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 5437600 | 5728246 | 10701227 | 10847431 |
| Income from operations | 739350 | 92847 | 1701021 | 739538 |
| &nbsp;&nbsp;Other income | 95065 | 348999 | 221978 | 417524 |
| &nbsp;&nbsp;Change in fair value of contingent earnout liability | (278637) | (2406886) | (596603) | (2406886) |
| Income (loss) before provision for income taxes | 555778 | (1965040) | 1326396 | (1249824) |
| Provision for income taxes | (8859) | (15194) | (30090) | (61406) |
| Net income (loss) | 546919 | (1980234) | 1296306 | (1311230) |
| **Other comprehensive income (loss):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation | 5859 | 2637 | 6826 | (3531) |
| Comprehensive income (loss) | $552778 | $(1977597) | $1303132 | $(1314761) |
| Basic income (loss) per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) per share | $0.02 | $(0.07) | $0.04 | $(0.04) |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding | 31634575 | 30421808 | 31434725 | 30384339 |
| Diluted income (loss) per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) per share | $0.02 | $(0.07) | $0.04 | $(0.04) |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding | 32333657 | 30421808 | 32113408 | 30384339 |

---

See notes to condensed consolidated financial statements

**Research Solutions, Inc. and Subsidiaries**

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **Cash flow from operating activities:** |  |  |
| &nbsp;&nbsp;Net income (loss) | $1296306 | $(1311230) |
| &nbsp;&nbsp;Adjustment to reconcile net income (loss) to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 632491 | 618328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock options expense | 149262 | 88045 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted common stock expense | 276669 | 864266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment to contingent earnout liability | 596603 | 2406886 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 1530063 | (266255) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (127818) | (98613) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid royalties | (41230) | 478169 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (1035903) | (737670) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | (785267) | (170433) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 2491176 | 1871493 |
| **Cash flow from investing activities:** |  |  |
| &nbsp;&nbsp;Purchase of property and equipment | (24561) | (5404) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (24561) | (5404) |
| **Cash flow from financing activities:** |  |  |
| &nbsp;&nbsp;Proceeds from the exercise of stock options | 157500 |  |
| &nbsp;&nbsp;Common stock repurchases | (39549) | (205278) |
| &nbsp;&nbsp;Payment of contingent acquisition consideration - Scite and FIZ | (2554394) | (62560) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (2436443) | (267838) |
| Effect of exchange rate changes | 5296 | 2873 |
| Net increase in cash and cash equivalents | 35468 | 1601124 |
| Cash and cash equivalents, beginning of period | 12227312 | 6100031 |
| Cash and cash equivalents, end of period | $12262780 | $7701155 |
| **Supplemental disclosures of cash flow information:** |  |  |
| &nbsp;&nbsp;Cash paid for income taxes | $30090 | $61406 |
| **Non-cash investing and financing activities:** |  |  |
| &nbsp;&nbsp;Contingent consideration accrual on asset acquisition | $20981 | $30198 |
| &nbsp;&nbsp;Common stock issued for Scite earnout payment | $1453428 | $— |

---

See notes to condensed consolidated financial statements

**Contact**

Steven Hooser or John Beisler

Three Part Advisors

(214) 872-2710

<u>shooser@threepa.com</u>; <u>jbeisler@threepa.com</u>

# # #